BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Natsuizaka M, Omura T, Akaike T, Kuwata Y, Yamazaki K, Sato T, Karino Y, Toyota J, Suga T, Asaka M. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol. 2005;20:1781-1787. [PMID: 16246200 DOI: 10.1111/j.1440-1746.2005.03919.x] [Cited by in Crossref: 298] [Cited by in F6Publishing: 281] [Article Influence: 19.9] [Reference Citation Analysis]
Number Citing Articles
1 Uka K, Aikata H, Takaki S, Shirakawa H, Jeong SC, Yamashina K, Hiramatsu A, Kodama H, Takahashi S, Chayama K. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 2007; 13(3): 414-420 [PMID: 17230611 DOI: 10.3748/wjg.v13.i3.414] [Cited by in CrossRef: 228] [Cited by in F6Publishing: 219] [Article Influence: 16.3] [Reference Citation Analysis]
2 Malaviya L, Shields CL, Turaka K, Ehya H, Shields JA. Choroidal metastasis from hepatocellular carcinoma, diagnosed by fine needle aspiration biopsy and treated by iodine-125 brachytherapy. Graefes Arch Clin Exp Ophthalmol. 2011;249:1095-1098. [PMID: 21305314 DOI: 10.1007/s00417-011-1626-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Choi C, Seong J. Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma. Gut Liver. 2015;9:94-102. [PMID: 25071067 DOI: 10.5009/gnl14009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
4 Chen J. The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis. PLoS One 2018;13:e0200909. [PMID: 30102707 DOI: 10.1371/journal.pone.0200909] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sheng S, Zheng J, Cui S, Cui X, Qian Z. Complete remission of multiple lung metastases after ablation of hepatocellular carcinoma by transarterial infusion with the p53 gene. Anti-Cancer Drugs 2015;26:227-31. [DOI: 10.1097/cad.0000000000000167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Qian L, Huang J, Qin H. Glypican-3-expressing gastric metastasis of hepatocellular carcinoma via curative subtotal gastrectomy: a case report. J Gastrointest Cancer 2014;45 Suppl 1:166-9. [PMID: 24777446 DOI: 10.1007/s12029-014-9613-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, Ensminger WD, Gibbs JF, Laheru D, Malafa MP, Marrero J, Meranze SG, Mulvihill SJ, Park JO, Posey JA, Sachdev J, Salem R, Sigurdson ER, Sofocleous C, Vauthey JN, Venook AP, Goff LW, Yen Y, Zhu AX. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009;7:350-391. [PMID: 19406039 DOI: 10.6004/jnccn.2009.0027] [Cited by in Crossref: 299] [Cited by in F6Publishing: 324] [Article Influence: 24.9] [Reference Citation Analysis]
8 Katamura Y, Aikata H, Hashimoto Y, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S. Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma. Hepatol Res. 2010;40:1195-1203. [PMID: 21040275 DOI: 10.1111/j.1872-034x.2010.00729.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ueda J, Yoshida H, Mamada Y, Taniai N, Mineta S, Yoshioka M, Kawano Y, Shimizu T, Hara E, Kawamoto C, Kaneko K, Uchida E. Surgical resection of a solitary para-aortic lymph node metastasis from hepatocellular carcinoma. World J Gastroenterol 2012; 18(23): 3027-3031 [PMID: 22736929 DOI: 10.3748/wjg.v18.i23.3027] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
10 Furumoto K, Miura K, Nagashima D, Kojima H, Mori T, Ito D, Kajimura K, Kogire M. Solitary metastasis to the intercostal muscle from hepatocellular carcinoma: A case report. Int J Surg Case Rep. 2012;3:322-326. [PMID: 22554941 DOI: 10.1016/j.ijscr.2012.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
11 Pham BV, Phan HH, Ngo LL, Nguyen HTT, Le KV, Dinh TC, Bac ND. A Rare Colonic Metastasis Case from Hepatocellular Carcinoma. Open Access Maced J Med Sci 2019;7:4368-71. [PMID: 32215096 DOI: 10.3889/oamjms.2019.837] [Reference Citation Analysis]
12 Holliday EB, Allen PK, Elhalawani H, Abdel-rahman O. Treatment at a high-volume centre is associated with improved survival among patients with non-metastatic hepatocellular carcinoma. Liver Int 2018;38:665-75. [DOI: 10.1111/liv.13561] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
13 Alraiyes AH, Altahawi F, Shaheen K, Alraies MC. Abdominal pain and heart failure: a grim diagnosis. Am J Med 2012;125:34-6. [PMID: 22055250 DOI: 10.1016/j.amjmed.2011.07.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Jiang H, Zhao S, Li G. Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report. Medicine (Baltimore) 2020;99:e23263. [PMID: 33217850 DOI: 10.1097/MD.0000000000023263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yoo DJ, Chung YH, Lee YS, Kim SE, Jin YJ, Lee YM, Kim MJ. Sigmoid colon metastasis from hepatocellular carcinoma. Korean J Hepatol 2010;16:397-400. [PMID: 21415584 DOI: 10.3350/kjhep.2010.16.4.397] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Xiang Z, Zeng Z, Tang Z, Fan J, Sun H, Wu W, Tan Y. Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome. Cancer J 2009;15:519-25. [PMID: 20010172 DOI: 10.1097/PPO.0b013e3181c6aa6b] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
17 Koh PS, Yusof MM, Yoong BK, Rajadurai P. Mediastinal hepatocellular carcinoma with unknown primary: an unusual and rare presentation. J Gastrointest Cancer 2014;45 Suppl 1:74-6. [PMID: 24045908 DOI: 10.1007/s12029-013-9549-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Zhang T, Huang J, Bai Y, Wu H, Zeng Y. Recurrence and survivals following hepatic resection for hepatocellular carcinoma with major portal/hepatic vein tumor thrombus: Resection of HCC with tumor thrombus. Hepatol Res 2014;44:761-8. [DOI: 10.1111/hepr.12185] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
19 Sneag DB, Krajewski K, Giardino A, O'Regan KN, Shinagare AB, Jagannathan JP, Ramaiya N. Extrahepatic spread of hepatocellular carcinoma: spectrum of imaging findings. AJR Am J Roentgenol 2011;197:W658-64. [PMID: 21940537 DOI: 10.2214/AJR.10.6402] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
20 Bettinger D, Spode R, Glaser N, Buettner N, Boettler T, Neumann-Haefelin C, Brunner TB, Gkika E, Maruschke L, Thimme R, Schultheiss M. Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience. BMC Gastroenterol 2017;17:98. [PMID: 28797231 DOI: 10.1186/s12876-017-0656-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
21 He F, Li J, Xu J, Zhang S, Xu Y, Zhao W, Yin Z, Wang X. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:47. [PMID: 25975202 DOI: 10.1186/s13046-015-0164-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
22 Hwang SH, Lee JW, Cho HJ, Kim KS, Choi GH, Yun M. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma. Clin Nucl Med. 2017;42:34-39. [PMID: 27775949 DOI: 10.1097/rlu.0000000000001449] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Zhang L, Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zhao XM. A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma. Oncotarget 2016;7:3587-98. [PMID: 26657296 DOI: 10.18632/oncotarget.6534] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
24 Chua TC, Morris DL. Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma. Surg Oncol. 2012;21:95-101. [PMID: 21397495 DOI: 10.1016/j.suronc.2011.01.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
25 Lee JE, Jang JY, Jeong SW, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Jin SY, Choi DL. Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan. World J Gastroenterol 2012; 18(23): 2979-2987 [PMID: 22736922 DOI: 10.3748/wjg.v18.i23.2979] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
26 Ou TM, Tsai WC, Hsieh TY, Shih YL. Hepatocellular carcinoma with colonic metastasis. Singapore Med J 2014;55:e93-5. [PMID: 24442188 DOI: 10.11622/smedj.2013262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Abbas A, Medvedev S, Shores N, Bazzano L, Dehal A, Hutchings J, Balart L. Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective. Dig Dis Sci 2014;59:2813-20. [PMID: 24903653 DOI: 10.1007/s10620-014-3229-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
28 Ye G, Wang L, Hu Z, Liang J, Bian Y, Zhan C, Lin Z. Risk and prognostic nomograms for hepatocellular carcinoma with newly-diagnosed pulmonary metastasis using SEER data. PeerJ 2019;7:e7496. [PMID: 31440435 DOI: 10.7717/peerj.7496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Han TS, Ban HS, Hur K, Cho HS. The Epigenetic Regulation of HCC Metastasis. Int J Mol Sci 2018;19:E3978. [PMID: 30544763 DOI: 10.3390/ijms19123978] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
30 Jiang W, Zeng ZC. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma? Oncology. 2013;84 Suppl 1:69-74. [PMID: 23428862 DOI: 10.1159/000345893] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
31 Zhou X, Zimonjic DB, Park SW, Yang XY, Durkin ME, Popescu NC. DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis. Int J Oncol 2008;32:1285-91. [PMID: 18497990 DOI: 10.3892/ijo_32_6_1285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 22] [Article Influence: 0.2] [Reference Citation Analysis]
32 Berger Y, Spivack JH, Heskel M, Aycart SN, Labow DM, Sarpel U. Extrahepatic metastasectomy for hepatocellular carcinoma: Predictors of long-term survival. J Surg Oncol. 2016;114:469-474. [PMID: 27334650 DOI: 10.1002/jso.24340] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
33 Senthilnathan S, Memon K, Lewandowski RJ, Kulik L, Mulcahy MF, Riaz A, Miller FH, Yaghmai V, Nikolaidis P, Wang E. Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients. Hepatology. 2012;55:1432-1442. [PMID: 22109811 DOI: 10.1002/hep.24812] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
34 Pai A, Lin A. Chronic asymptomatic hepatitis B presenting with metastatic hepatocellular carcinoma. J Clin Oncol 2008;26:4209-11. [PMID: 18757338 DOI: 10.1200/JCO.2008.16.0523] [Reference Citation Analysis]
35 He J, Zeng ZC, Xiang ZL, Yang P. Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis. World J Gastroenterol 2014; 20(11): 3025-3032 [PMID: 24659894 DOI: 10.3748/wjg.v20.i11.3025] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
36 Mroz RM, Korniluk M, Swidzinska E, Dzieciol J, Czaban J, Panek B, Chyczewska E. Lung mass in a 28-year-old male: a case report of a rare tumor. Eur J Med Res 2010;15 Suppl 2:95-7. [PMID: 21147631 DOI: 10.1186/2047-783x-15-s2-95] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Chang C, Huang T, Lin K, Hsu C, Chang W, Wang S, Ko F, Peng H, Chung C. 4-Acetylantroquinonol B Suppresses Tumor Growth and Metastasis of Hepatoma Cells via Blockade of Translation-Dependent Signaling Pathway and VEGF Production. J Agric Food Chem 2015;63:208-15. [DOI: 10.1021/jf504434v] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
38 Li S, Wang Q, Mei J, Wang J, Zhong XP, Ling Y, Guo Z, Lu LH, Wei W, Guo R. Risk factors of extra-hepatic progression after transarterial chemoembolization for hepatocellular carcinoma patients: a retrospective study in 654 cases. J Cancer 2019;10:5007-14. [PMID: 31598173 DOI: 10.7150/jca.35355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Lee HS. Management of patients with hepatocellular carcinoma and extrahepatic metastasis. Dig Dis. 2011;29:333-338. [PMID: 21829026 DOI: 10.1159/000327572] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
40 Yamada N, Matsushima-nishiwaki R, Kozawa O. Quercetin suppresses the migration of hepatocellular carcinoma cells stimulated by hepatocyte growth factor or transforming growth factor-α: Attenuation of AKT signaling pathway. Archives of Biochemistry and Biophysics 2020;682:108296. [DOI: 10.1016/j.abb.2020.108296] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
41 Mantonakis EI, Margariti TS, Petrou AS, Stofas AC, Lazaris AC, Papalampros AE, Moris DN, Michail PO. A pathological fracture and a solitary mass in the right clavicle: an unusual first presentation of HCC and the role of immunohistochemistry. World J Surg Oncol 2012;10:50. [PMID: 22400493 DOI: 10.1186/1477-7819-10-50] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Walter CM, Kirby EJ, Vasconez HC, Rinker BD. Hepatocellular carcinoma metastatic to the scalp. J Craniofac Surg 2011;22:720-1. [PMID: 21415643 DOI: 10.1097/SCS.0b013e3182077843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
43 Ouyang L, Lee J, Park CK, Mao M, Shi Y, Gong Z, Zheng H, Li Y, Zhao Y, Wang G, Fu H, Kim J, Lim HY. Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas. BMC Med Genomics 2014;7:2. [PMID: 24405831 DOI: 10.1186/1755-8794-7-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
44 Rodrigues MFSD, Esteves CM, de Oliveira MA, de Andrade NP, Sedassari BT, Soares FA, Nunes FD. Fatal hepatocellular carcinoma presenting with oral metastasis in a patient with synchronic primary malignancies of prostate and liver. Gerodontology 2017;34:272-5. [PMID: 27207742 DOI: 10.1111/ger.12236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
45 Takahashi K, Putchakayala KG, Safwan M, Kim DY. Extrahepatic metastasis of hepatocellular carcinoma to the paravertebral muscle: A case report. World J Hepatol 2017; 9(22): 973-978 [PMID: 28839518 DOI: 10.4254/wjh.v9.i22.973] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
46 Longo V, Brunetti O, D’oronzo S, Ostuni C, Gatti P, Silvestris F. Bone metastases in hepatocellular carcinoma: an emerging issue. Cancer Metastasis Rev 2014;33:333-42. [DOI: 10.1007/s10555-013-9454-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
47 Gao Q, Zhou J, Wang XY, Qiu SJ, Song K, Huang XW, Sun J, Shi YH, Li BZ, Xiao YS, Fan J. Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma. Ann Surg Oncol 2012;19:455-66. [PMID: 21792513 DOI: 10.1245/s10434-011-1864-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
48 Xiang ZL, Zeng ZC, Tang ZY, Fan J, Sun HC, Tan YS. Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma. Mol Biol Rep. 2011;38:3531-3539. [PMID: 21104440 DOI: 10.1007/s11033-010-0463-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
49 Bharadwaj M, Roy G, Dutta K, Misbah M, Husain M, Hussain S. Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now. Cancer Metastasis Rev. 2013;32:229-268. [PMID: 23114844 DOI: 10.1007/s10555-012-9412-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
50 Chen H, Li J, Wang L, Cong N, Shi C, Song J, Bu W. Hepatocellular carcinoma metastasis to the lacrimal gland: A case report. Oncol Lett 2014;8:911-3. [PMID: 25013516 DOI: 10.3892/ol.2014.2191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
51 Sano T, Izuishi K, Takebayashi R, Masaki T, Suzuki Y. Operative management of solitary intra-abdominal recurrence of hepatocellular carcinoma. Surgery 2010;147:311. [PMID: 19945131 DOI: 10.1016/j.surg.2009.10.046] [Reference Citation Analysis]
52 Wu D, Wei S, Liu B, Wu X, Feng Y, Luo C, Ju Y, Liang J. Effect of immune suppression on metastasis in a patient with hepatocellular carcinoma metastasized to the colon and stomach: A case report. Exp Ther Med 2016;11:1741-7. [PMID: 27168796 DOI: 10.3892/etm.2016.3108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
53 Chaudhary D, Patkar S, Shrikhande SV, Goel M. Metastasis from Hepatocellular Carcinoma Masquerading as a Jugular Paraganglioma. J Gastrointest Cancer 2018;49:517-9. [PMID: 28374273 DOI: 10.1007/s12029-017-9943-8] [Reference Citation Analysis]
54 Kim TG, Park HC, Lim DH, Kim CJ, Lee HB, Kwak KY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Radiation Therapy for Bone Metastases from Hepatocellular Carcinoma: Effect of Radiation Dose Escalation. J Korean Soc Ther Radiol Oncol 2011;29:63. [DOI: 10.3857/jkstro.2011.29.2.63] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
55 Oweira H, Petrausch U, Helbling D, Schmidt J, Mehrabi A, Schöb O, Giryes A, Abdel-Rahman O. Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis. Expert Rev Gastroenterol Hepatol 2017;11:695-701. [PMID: 28276812 DOI: 10.1080/17474124.2017.1294485] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
56 Wu W, He X, Andayani D, Yang L, Ye J, Li Y, Chen Y, Li L. Pattern of distant extrahepatic metastases in primary liver cancer: a SEER based study. J Cancer 2017;8:2312-8. [PMID: 28819435 DOI: 10.7150/jca.19056] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
57 Kyrochristos ID, Glantzounis GK, Ziogas DE, Gizas I, Schizas D, Lykoudis EG, Felekouras E, Machairas A, Katsios C, Liakakos T, Cho WC, Roukos DH. From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers. Int J Mol Sci 2017;18:E180. [PMID: 28106782 DOI: 10.3390/ijms18010180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
58 Liu TA, Jan YJ, Ko BS, Chen SC, Liang SM, Hung YL, Hsu C, Shen TL, Lee YM, Chen PF, Wang J, Shyue SK, Liou JY. Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma. Am J Pathol 2011;179:2698-708. [PMID: 21967815 DOI: 10.1016/j.ajpath.2011.08.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
59 Sohn S, Chung CK, Sohn MJ, Kim SH, Kim J, Park E. Radiosurgery Compared with External Radiation Therapy as a Primary Treatment in Spine Metastasis from Hepatocellular Carcinoma : A Multicenter, Matched-Pair Study. J Korean Neurosurg Soc 2016;59:37-43. [PMID: 26885284 DOI: 10.3340/jkns.2016.59.1.37] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
60 Lyu N, Kong Y, Pan T, Mu L, Sun X, Li S, Deng H, Lai J, Zhao M. Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma. International Journal of Hyperthermia 2019;36:1002-10. [DOI: 10.1080/02656736.2019.1663279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Kanzaki R, Yamada T, Gotoh K, Takahashi H, Murata M, Tomita Y, Yano M, Ohigashi H, Sasaki Y, Ishikawa O. Surgical resection for hepatocellular carcinoma with metastasis to the gallbladder: report of a case. Surg Today 2011;41:285-91. [PMID: 21264771 DOI: 10.1007/s00595-010-4223-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
62 Chan KM, Yu MC, Wu TJ, Lee CF, Chen TC, Lee WC, Chen MF. Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J Gastroenterol 2009; 15(43): 5481-5488 [PMID: 19916180 DOI: 10.3748/wjg.15.5481] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
63 Kamimura K, Kobayashi Y, Takahashi Y, Abe H, Kumaki D, Yokoo T, Kamimura H, Sakai N, Sakamaki A, Abe S. Tumor markers for early diagnosis for brain metastasis of hepatocellular carcinoma: A case series and literature review for effective loco-regional treatment. Cancer Biol Ther. 2017;18:79-84. [PMID: 28045618 DOI: 10.1080/15384047.2016.1276134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
64 Shaaban A, Salamah R, Abo Elseud Y, Mohanty A, Albarrak J. Presentation and Outcomes of Hepatocellular Carcinoma in the Arabian Peninsula: A Review of a Single Institution Experience in the Sorafenib Era. J Gastrointest Cancer 2021;52:85-9. [PMID: 31808059 DOI: 10.1007/s12029-019-00341-7] [Reference Citation Analysis]
65 Schütte K, Schinner R, Fabritius MP, Möller M, Kuhl C, Iezzi R, Öcal O, Pech M, Peynircioglu B, Seidensticker M, Sharma R, Palmer D, Bronowicki JP, Reimer P, Malfertheiner P, Ricke J. Impact of Extrahepatic Metastases on Overall Survival in Patients with Advanced Liver Dominant Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial. Liver Cancer 2020;9:771-86. [PMID: 33442545 DOI: 10.1159/000510798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Kornberger A, Emrich T, Beiras-Fernandez A, Vahl CF. Restrictive surgical approach to palliate angina in a patient with coronary three vessel disease and biventricular metastatic hepatocellular carcinoma. World J Surg Oncol 2017;15:217. [PMID: 29212547 DOI: 10.1186/s12957-017-1256-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Choi HJ, Cho BC, Sohn JH, Shin SJ, Kim SH, Kim JH, Yoo NC. Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC. J Neurooncol. 2009;91:307-313. [PMID: 18949445 DOI: 10.1007/s11060-008-9713-3] [Cited by in Crossref: 81] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
68 Royer MC, Rush WL, Lupton GP. Hepatocellular carcinoma presenting as a precocious cutaneous metastasis. Am J Dermatopathol. 2008;30:77-80. [PMID: 18212552 DOI: 10.1097/DAD.0b013e31815ea24f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
69 He G, Hu S, Zhang D, Wu P, Zhu X, Xin S, Lu G, Ding Y, Liang L. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma. Experimental and Molecular Pathology 2015;99:374-82. [DOI: 10.1016/j.yexmp.2015.06.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
70 Hsu CY, Liu PH, Ho SY, Huang YH, Lee YH, Lee RC, Nagaria TS, Hou MC, Huo TI. Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system. Liver Int 2018;38:1803-11. [PMID: 29608816 DOI: 10.1111/liv.13748] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
71 Tagliabue F, Burati M, Chiarelli M, Marando A, Simone MD, Cioffi U. Left colonic metastasis from primary hepatocellular carcinoma: A case report. World J Clin Cases 2019; 7(15): 2044-2048 [PMID: 31423436 DOI: 10.12998/wjcc.v7.i15.2044] [Reference Citation Analysis]
72 Szpakowski JL, Drasin TE, Lyon LL. Rate of seeding with biopsies and ablations of hepatocellular carcinoma: A retrospective cohort study. Hepatol Commun 2017;1:841-51. [PMID: 29404497 DOI: 10.1002/hep4.1089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
73 Matsushima-Nishiwaki R, Toyoda H, Nagasawa T, Yasuda E, Chiba N, Okuda S, Maeda A, Kaneoka Y, Kumada T, Kozawa O. Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-α-Induced Migration and Invasion of Hepatocellular Carcinoma Cells. PLoS One 2016;11:e0151907. [PMID: 27046040 DOI: 10.1371/journal.pone.0151907] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
74 Wang E, Liu L, Xia D, Wang W, Bai W, Wang Q, Yuan J, Li X, Zhang L, Niu J, Yin Z, Xia J, Cai H, Fan D, Han G. Chemoembolization for Hepatocellular Carcinoma in Patients with Extrahepatic Spread: Prognostic Determinants and Appropriate Candidates. J Vasc Interv Radiol 2017;28:956-62. [PMID: 28420555 DOI: 10.1016/j.jvir.2017.02.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Hu J, Wang T, Zhang KH, Jiang YP, Xu S, Chen SH, He YT, Yuan HL, Wang YQ. Pretreatment risk management of a novel nomogram model for prediction of thoracoabdominal extrahepatic metastasis in primary hepatic carcinoma. J Transl Med 2019;17:117. [PMID: 30961629 DOI: 10.1186/s12967-019-1861-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
76 Hu B, An HM, Yan X, Zheng JL, Huang XW, Li M. Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells. BMC Complement Altern Med 2019;19:67. [PMID: 30876428 DOI: 10.1186/s12906-019-2477-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
77 Yang T, Lu JH, Lin C, Shi S, Chen TH, Zhao RH, Wang Y, Wu MC. Concomitant lung metastasis in patients with advanced hepatocellular carcinoma. World J Gastroenterol 2012; 18(20): 2533-2539 [PMID: 22654451 DOI: 10.3748/wjg.v18.i20.2533] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
78 Chen CC, Yeh HZ, Chang CS, Ko CW, Lien HC, Wu CY, Hung SW. Transarterial embolization of metastatic mediastinal hepatocellular carcinoma. World J Gastroenterol 2013; 19(22): 3512-3516 [PMID: 23801848 DOI: 10.3748/wjg.v19.i22.3512] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
79 Maehara O, Sato F, Natsuizaka M, Asano A, Kubota Y, Itoh J, Tsunematsu S, Terashita K, Tsukuda Y, Nakai M, Sho T, Suda G, Morikawa K, Ogawa K, Chuma M, Nakagawa K, Ohnishi S, Komatsu Y, Whelan KA, Nakagawa H, Takeda H, Sakamoto N. A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma. Cancer Biol Ther 2015;16:1453-61. [PMID: 26176896 DOI: 10.1080/15384047.2015.1070992] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
80 Bhagwandin SB, Salti GI. Hepatocellular carcinoma with peritoneal metastasis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Tumori 2015;101:e1-3. [PMID: 25702649 DOI: 10.5301/tj.5000197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
81 Kanda M, Tateishi R, Yoshida H, Sato T, Masuzaki R, Ohki T, Imamura J, Goto T, Hamamura K, Obi S, Kanai F, Shiina S, Omata M. Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors. Liver Int. 2008;28:1256-1263. [PMID: 18710423 DOI: 10.1111/j.1478-3231.2008.01864.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
82 Chan S, Leow WQ. Sudden Collapse due to Medullary and Cervical Cord Infarction-An Unusual Presentation of Hepatocellular Carcinoma. J Forensic Sci 2019;64:925-9. [PMID: 30352122 DOI: 10.1111/1556-4029.13929] [Reference Citation Analysis]
83 Yoon JH, Goo YJ, Lim CJ, Choi SK, Cho SB, Shin SS, Jun CH. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol 2020; 26(32): 4833-4845 [PMID: 32921960 DOI: 10.3748/wjg.v26.i32.4833] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
84 Huang SF, Chou JW, Lai HC. A rare cause of bloody stools in a 57-year-old woman with hepatocellular carcinoma. Gastroenterology 2011;140:e5-6. [PMID: 21182954 DOI: 10.1053/j.gastro.2010.01.065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
85 Yang B, Li M, Tang W, Liu W, Zhang S, Chen L, Xia J. Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma. Nat Commun 2018;9:678. [PMID: 29445139 DOI: 10.1038/s41467-018-03024-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 21.3] [Reference Citation Analysis]
86 Kumar D, Hafez O, Jain D, Zhang X. Can primary hepatocellular carcinoma histomorphology predict extrahepatic metastasis? Hum Pathol 2021;113:39-46. [PMID: 33905775 DOI: 10.1016/j.humpath.2021.04.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Kwon JH. Is percutaneous ethanol injection therapy still effective for hepatocellular carcinoma in the era of radiofrequency ablation? Gut Liver. 2010;4 Suppl 1:S105-S112. [PMID: 21103288 DOI: 10.5009/gnl.2010.4.s1.s105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
88 Honda Y, Takahashi S, Zhang Y, Ono A, Murakami E, Shi N, Kawaoka T, Miki D, Tsuge M, Hiraga N. Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway. J Gastroenterol Hepatol. 2015;30:619-627. [PMID: 25167891 DOI: 10.1111/jgh.12715] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
89 Ito J, Saito T, Iwaba A, Suzuki Y, Sanjo M, Ishii R, Sato C, Haga H, Okumoto K, Nishise Y, Watanabe H, Saito K, Togashi H, Kawata S. A case of monocular blindness as the initial presentation of hepatocellular carcinoma with skull metastasis. Clin J Gastroenterol 2011;4:273-7. [PMID: 26189533 DOI: 10.1007/s12328-011-0237-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Ko BS, Lai IR, Chang TC, Liu TA, Chen SC, Wang J, Jan YJ, Liou JY. Involvement of 14-3-3γ overexpression in extrahepatic metastasis of hepatocellular carcinoma. Hum Pathol 2011;42:129-35. [PMID: 20870266 DOI: 10.1016/j.humpath.2010.01.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
91 Kwon MJ, Ryu SH, Jo SY, Kwak CH, Yoon WJ, Moon JS, Lee HK. A Case of Hepatocellular Carcinoma Presenting as a Gingival Mass. Korean J Gastroenterol 2016;68:321-5. [PMID: 28025476 DOI: 10.4166/kjg.2016.68.6.321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
92 Yamakado K, Anai H, Takaki H, Sakaguchi H, Tanaka T, Kichikawa K, Takeda K. Adrenal metastasis from hepatocellular carcinoma: radiofrequency ablation combined with adrenal arterial chemoembolization in six patients. AJR Am J Roentgenol. 2009;192:W300-W305. [PMID: 19457793 DOI: 10.2214/ajr.08.1752] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
93 Shih KL, Chen YY, Teng TH, Soon MS. Long-term survival in a patient with repeated resections for lung metastasis after hepatectomy for ruptured hepatocellular carcinoma: a case report. J Med Case Rep 2008;2:222. [PMID: 18588711 DOI: 10.1186/1752-1947-2-222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
94 Ito S, Yoshimura T, Kondo T, Tamura K, Yamashita N, Hanawa T. Long-term survival with chest wall resection and pulmonary metastasectomy for hepatocellular carcinoma. Ann Thorac Surg 2015;99:695-8. [PMID: 25639412 DOI: 10.1016/j.athoracsur.2014.03.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
95 Ghasemi R, Ghaffari SH, Momeny M, Pirouzpanah S, Yousefi M, Malehmir M, Alimoghaddam K, Ghavamzadeh A. Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells. Nutr Cancer. 2013;65:590-599. [PMID: 23659451 DOI: 10.1080/01635581.2013.770043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
96 Miyabe-Nishiwaki T, Hirata A, Kaneko A, Ishigami A, Miyamoto Y, Yamanaka A, Owaki K, Sakai H, Yanai T, Suzuki J. Hepatocellular carcinoma with intracranial metastasis in a Japanese macaque (Macaca fuscata). J Med Primatol 2017;46:93-100. [PMID: 28369930 DOI: 10.1111/jmp.12261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
97 Seo HJ, Kim GM, Kim JH, Kang WJ, Choi HJ. 18F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis. Nucl Med Commun. 2015;36:226-233. [PMID: 25460306 DOI: 10.1097/mnm.0000000000000246] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
98 Di Meglio G, Fazio N, Nolè F, Della Vigna P, Lorizzo K, Goldhirsch A, Farris A. Successful treatment with low-dose oral chemotherapy in a patient with metastatic hepatocellular carcinoma. Acta Oncol 2007;46:1205-6. [PMID: 17978934 DOI: 10.1080/02841860701403079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
99 Kawamura M, Nakajima J, Matsuguma H, Horio H, Miyoshi S, Nakagawa K, Fujisawa T, Kobayashi K; Metastatic Lung Tumor Study Group of Japan. Surgical outcomes for pulmonary metastases from hepatocellular carcinoma. Eur J Cardiothorac Surg 2008;34:196-9. [PMID: 18455409 DOI: 10.1016/j.ejcts.2008.03.056] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
100 Orita K, Sakamoto A, Okamoto T, Matsuda S. Solitary Muscle Metastasis of Hepatocellular Carcinoma to the Biceps Femoris Muscle with Only Elevated Serum PIVKA-II: A Case Report. Am J Case Rep. 2019;20:306-309. [PMID: 30846677 DOI: 10.12659/ajcr.913730] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
101 Lai SW. Pathologic evaluation of gallbladder in patients who underwent cholecystectomy and hepatic resection for hepatocellular carcinoma. Am J Med Sci 2011;341:305-7. [PMID: 21289505 DOI: 10.1097/MAJ.0b013e3182061674] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Jung SM, Jang JW, You CR, Yoo SH, Kwon JH, Bae SH, Choi JY, Yoon SK, Chung KW, Kay CS, Jung HS. Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases. J Gastroenterol Hepatol. 2012;27:684-689. [PMID: 21916984 DOI: 10.1111/j.1440-1746.2011.06917.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
103 López F, Rodrigo JP, Silver CE, Haigentz M Jr, Bishop JA, Strojan P, Hartl DM, Bradley PJ, Mendenhall WM, Suárez C, Takes RP, Hamoir M, Robbins KT, Shaha AR, Werner JA, Rinaldo A, Ferlito A. Cervical lymph node metastases from remote primary tumor sites. Head Neck 2016;38 Suppl 1:E2374-85. [PMID: 26713674 DOI: 10.1002/hed.24344] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
104 Teegen EM, Mogl MT, Pratschke J, Rayes N. Adrenal Metastasis of Hepatocellular Carcinoma in Patients following Liver Resection or Liver Transplantation: Experience from a Tertiary Referral Center. Int J Surg Oncol 2018;2018:4195076. [PMID: 30151282 DOI: 10.1155/2018/4195076] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Toshikuni N, Morii K, Yamamoto M. Radiotherapy for multiple brain metastases from hepatocellular carcinomas. World J Gastroenterol 2007; 13(33): 4520-4522 [PMID: 17724813 DOI: 10.3748/wjg.v13.i33.4520] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
106 Lee CH, Chang CJ, Lin YJ, Yen CL, Shen CH, Cheng YT, Lin CC, Hsieh SY. Nomogram predicting extrahepatic metastasis of hepatocellular carcinoma based on commonly available clinical data. JGH Open. 2019;3:38-45. [PMID: 30834339 DOI: 10.1002/jgh3.12102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
107 Kim JS, You CR, Jang JW, Bae SH, Choi JY, Yoon SK, Kay CS. Application of helical tomotherapy for two cases of advanced hepatocellular carcinoma. Korean J Intern Med 2011;26:201-6. [PMID: 21716911 DOI: 10.3904/kjim.2011.26.2.201] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
108 Yan J, Zhuo S, Chen G, Tan C, Zhu W, Lu J, Fan J, Chen J, Zhou J. Use of Multiphoton Microscopy to Diagnose Liver Cancer and Lung Metastasis in an Orthotopic Rat Model: Multiphoton microscopy liver cancer lung metastasis. SCANNING 2012;34:271-7. [DOI: 10.1002/sca.21005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
109 Sohn W, Paik YH, Cho JY, Lim HY, Ahn JM, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: treatment outcome and prognostic factors. J Hepatol. 2015;62:1112-1121. [PMID: 25514557 DOI: 10.1016/j.jhep.2014.12.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
110 Carrafiello G, Laganà D, Ianniello A, Nicotera P, Fontana F, Dizonno M, Cuffari S, Fugazzola C. Radiofrequency thermal ablation for pain control in patients with single painful bone metastasis from hepatocellular carcinoma. Eur J Radiol 2009;71:363-8. [PMID: 18514456 DOI: 10.1016/j.ejrad.2008.04.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
111 Wang F, Lv H, Li Y, Han T, Liu H, Jia K, Liu F, Gao Y, Wang F. Complete cure of a patient with HBV-associated hepatocellular carcinoma with lung metastasis using interferon and survival up to 108 months: A case report and literature review. Oncol Lett 2018;16:2979-88. [PMID: 30127887 DOI: 10.3892/ol.2018.9033] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Yu K, Tang J, Wu JL, Li B, Wu SN, Zhang MY, Li QY, Zhang LJ, Pan YC, Ge QM, Shu HY, Shao Y. Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125. World J Diabetes 2021; 12(2): 158-169 [PMID: 33594335 DOI: 10.4239/wjd.v12.i2.158] [Reference Citation Analysis]
113 Esmaeilzadeh M, Majlesara A, Faridar A, Hafezi M, Hong B, Esmaeilnia-Shirvani H, Neyazi B, Mehrabi A, Nakamura M. Brain metastasis from gastrointestinal cancers: a systematic review. Int J Clin Pract 2014;68:890-9. [PMID: 24666726 DOI: 10.1111/ijcp.12395] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
114 Wang XY, Gao F, Sun YR, Bai LL, Ibrahim MM, Wang B, Tang JW. In vivo and in vitro effect of hepatocarcinoma lymph node metastasis by upregulation of Annexin A7 and relevant mechanisms. Tumour Biol 2016;37:911-24. [PMID: 26256045 DOI: 10.1007/s13277-015-3691-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
115 Addario L, Tritto G, Cavaglià E, Amodio F, Giannelli E, Di Costanzo GG. Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma. Dig Liver Dis. 2011;43:319-324. [PMID: 20952262 DOI: 10.1016/j.dld.2010.09.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
116 Ryu HS, Hwang ET, Choi CS, Kim TH, Kim HC, Yun KJ, Park DE. A case of hepatocellular carcinoma invading the gallbladder misdiagnosed as a primary gallbladder carcinoma. Korean J Hepatol 2009;15:80. [DOI: 10.3350/kjhep.2009.15.1.80] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
117 Matsushima-nishiwaki R, Toyoda H, Takamatsu R, Yasuda E, Okuda S, Maeda A, Kaneoka Y, Yoshimi N, Kumada T, Kozawa O. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017;1863:1629-39. [DOI: 10.1016/j.bbadis.2017.04.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
118 Laube R, Sabih AH, Strasser SI, Lim L, Cigolini M, Liu K. Palliative care in hepatocellular carcinoma.J Gastroenterol Hepatol. 2021;36:618-628. [PMID: 32627853 DOI: 10.1111/jgh.15169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
119 Wu D, Wei S, Liu B, Wu X, Feng Y, Luo C, Ju Y, Liang J. Effect of immune suppression on metastasis in a patient with hepatocellular carcinoma metastasized to the colon and stomach: A case report. Exp Ther Med. 2016;11:1741-1747. [PMID: 27168796 DOI: 10.3892/etm.2016.3108.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Xiang ZL, Zhao XM, Zhang L, Yang P, Fan J, Tang ZY, Zeng ZC. MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma. Oncotarget. 2016;7:87246-87256. [PMID: 27893432 DOI: 10.18632/oncotarget.13531] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
121 Zhang L, Chen J, Yong J, Qiao L, Xu L, Liu C. An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma. J Exp Clin Cancer Res 2019;38:384. [PMID: 31477177 DOI: 10.1186/s13046-019-1382-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
122 Chen D, Li Z, Song Q, Qian L, Xie B, Zhu J. Clinicopathological features and differential diagnosis of hepatocellular carcinoma in extrahepatic metastases. Medicine (Baltimore) 2018;97:e13356. [PMID: 30557986 DOI: 10.1097/MD.0000000000013356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
123 Li CL, Lin YK, Chen HA, Huang CY, Huang MT, Chang YJ. Smoking as an Independent Risk Factor for Hepatocellular Carcinoma Due to the α7-Nachr Modulating the JAK2/STAT3 Signaling Axis. J Clin Med 2019;8:E1391. [PMID: 31492006 DOI: 10.3390/jcm8091391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
124 Sasaki A, Ishikawa K, Haraguchi N, Inoue H, Ishio T, Shibata K, Ohta M, Kitano S, Mori M. Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis. Ann Surg Oncol 2007;14:1191-9. [DOI: 10.1245/s10434-006-9277-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
125 Zainal N, Hasbullah HH. Prolonged survival of metastatic hepatocellular carcinoma: a case report. J Gastrointest Oncol 2018;9:E6-8. [PMID: 29755781 DOI: 10.21037/jgo.2018.01.04] [Reference Citation Analysis]
126 Haruki K, Misawa T, Gocho T, Saito R, Shiba H, Akiba T, Yanaga K. Hepatocellular carcinoma with gastric metastasis treated by simultaneous hepatic and gastric resection: report of a case. Clin J Gastroenterol 2016;9:319-23. [PMID: 27484064 DOI: 10.1007/s12328-016-0677-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
127 Mashiko T, Masuoka Y, Nakano A, Tsuruya K, Hirose S, Hirabayashi K, Kagawa T, Nakagohri T. Intussusception due to hematogenous metastasis of hepatocellular carcinoma to the small intestine: A case report. World J Gastroenterol 2020; 26(42): 6698-6705 [PMID: 33268957 DOI: 10.3748/wjg.v26.i42.6698] [Reference Citation Analysis]
128 Ko BS, Chang TC, Hsu C, Chen YC, Shen TL, Chen SC, Wang J, Wu KK, Jan YJ, Liou JY. Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma. Histopathology. 2011;58:705-711. [PMID: 21401702 DOI: 10.1111/j.1365-2559.2011.03789.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
129 Kim HH, Kim YC, Park YH, Park JW, Kim JH, Park SY, Lee SC. Cervicogenic headache arising from hidden metastasis to cervical lymph node adjacent to the superficial cervical plexus -A case report-. Korean J Anesthesiol 2011;60:134-7. [PMID: 21390170 DOI: 10.4097/kjae.2011.60.2.134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
130 Sun T, He J, Zhang S, Sun J, Zeng M, Zeng Z. Simultaneous multitarget radiotherapy using helical tomotherapy and its combination with sorafenib for pulmonary metastases from hepatocellular carcinoma. Oncotarget 2016;7:48586-99. [PMID: 27191894 DOI: 10.18632/oncotarget.9374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
131 Lee DW, Lee KH, Kim HJ, Kim TY, Kim JS, Han SW, Oh DY, Kim JH, Im SA, Kim TY. A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma. BMC Cancer 2018;18:252. [PMID: 29506478 DOI: 10.1186/s12885-018-4039-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
132 Lee DW, Yim HJ, Seo YS, Na SK, Kim SY, Suh SJ, Hyun JJ, Jung SW, Jung YK, Koo JS, Kim JH, Yeon JE, Lee SW, Byun KS, Um SH. Prognostic assessment using a new substaging system for Barcelona clinic liver cancer stage C hepatocellular carcinoma: A nationwide study. Liver Int. 2019;39:1109-1119. [PMID: 30972935 DOI: 10.1111/liv.14117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
133 Jo S, Shim HK. A patient who has survived for a long period with repeated radiotherapies for multifocal extrahepatic metastases from hepatocellular carcinoma. Radiat Oncol J. 2013;31:267-272. [PMID: 24501717 DOI: 10.3857/roj.2013.31.4.267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
134 Kilickap S, Kars A, Hamaloglu E, Simsek H. A case of recurrent metastatic hepatocellular cancer controlled with immunotherapy and antiviral therapy following resection. Med Oncol 2009;26:501-5. [PMID: 19688614 DOI: 10.1007/s12032-008-9083-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
135 Li JJ, Liang Q, Sun GC. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. J Integr Med 2021;19:469-77. [PMID: 34538644 DOI: 10.1016/j.joim.2021.08.004] [Reference Citation Analysis]
136 Otsuji M, Matsunaga S, Koga H, Kawabata N, Imakiire T, Hiwaki T, Tashiro Y, Shirahama H, Komiya S. An atypical extrahepatic metastasis of the distal phalanx from hepatocellular carcinoma. Int J Clin Oncol 2009;14:159-62. [DOI: 10.1007/s10147-008-0806-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
137 Isa NM, Bong JJ, Ghani FA, Rose IM, Husain S, Azrif M. Cutaneous metastasis of hepatocellular carcinoma diagnosed by fine needle aspiration cytology and Hep Par 1 immunopositivity. Diagn Cytopathol 2012;40:1010-4. [PMID: 21563319 DOI: 10.1002/dc.21706] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
138 Lee HP, Yun JK, Jung HS, Moon DH, Lee GD, Choi S, Kim YH, Kim DK, Park SI, Kim HR. Surgical outcomes of pulmonary metastasectomy in hepatocellular carcinoma patients according to approach method: thoracoscopic versus open approach. World J Surg Oncol 2021;19:33. [PMID: 33516218 DOI: 10.1186/s12957-021-02138-0] [Reference Citation Analysis]
139 Nangolo HT, Roberto L, Segamwenge IL, Voigt A, Kidaaga F. Spinal cord compression: an unusual presentation of hepatocellular carcinoma. Pan Afr Med J 2014;19:363. [PMID: 25932076 DOI: 10.11604/pamj.2014.19.363.4323] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
140 Yan L, Jakate S, Reddy V, Gattuso P. Metastatic hepatocellular carcinoma diagnosed by fine needle aspiration: A clinical and cytologic study. Diagn Cytopathol 2018;46:495-500. [PMID: 29493103 DOI: 10.1002/dc.23920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Kolarević D, Tomasević Z, Boricić I, Rasić DM, Dekić NA, Milovanović Z, Jelić S. Metastasis of hepatocellular carcinoma presented as a tumor of the maxillary sinus and retrobulbar tumor. Vojnosanit Pregl 2011;68:359-62. [PMID: 21627021 DOI: 10.2298/vsp1104359k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
142 Hasegawa K, Makuuchi M, Kokudo N, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Matsuyama Y. Impact of Histologically Confirmed Lymph Node Metastases on Patient Survival After Surgical Resection for Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey. Annals of Surgery 2014;259:166-70. [DOI: 10.1097/sla.0b013e31828d4960] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
143 Ip BC, Hu KQ, Liu C, Smith DE, Obin MS, Ausman LM, Wang XD. Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice. Cancer Prev Res (Phila). 2013;6:1304-1316. [PMID: 24085778 DOI: 10.1158/1940-6207.capr-13-0178] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
144 Hwang SW, Lee JE, Lee JM, Hong SH, Lee MA, Chun HG, Chun HJ, Lee SH, Jung ES. Hepatocellular Carcinoma with Cervical Spine and Pelvic Bone Metastases Presenting as Unknown Primary Neoplasm. Korean J Gastroenterol. 2015;66:50-54. [PMID: 26194130 DOI: 10.4166/kjg.2015.66.1.50] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
145 Yoon JH, Lee WJ, Kim SM, Kim KT, Cho SB, Kim HJ, Ko YS, Kook HY, Jun CH, Choi SK, Kim BS, Cho SY, You HS, Lee Y, Son S. Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Sci Rep 2021;11:12984. [PMID: 34155324 DOI: 10.1038/s41598-021-92503-6] [Reference Citation Analysis]
146 Kim K, Kim TH, Kim TH, Seong J. Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis. J Hepatocell Carcinoma 2021;8:35-44. [PMID: 33604314 DOI: 10.2147/JHC.S290197] [Reference Citation Analysis]
147 Patel N, Sheehan-dare G, Weir J, Verma S, Fearfield L. Cutaneous metastasis as the first presentation of hepatocellular carcinoma: Clincal Observations in Hepatology. Hepatology 2018;67:1631-3. [DOI: 10.1002/hep.29615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
148 Choi SH, Chang JS, Jeong YH, Lee Y, Yun M, Seong J. FDG-PET predicts outcomes of treated bone metastasis following palliative radiotherapy in patients with hepatocellular carcinoma. Liver Int. 2014;34:1118-1125. [PMID: 24528941 DOI: 10.1111/liv.12487] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
149 Kwak MS, Lee JH, Yoon JH, Yu SJ, Cho EJ, Jang ES, Kim YJ, Lee HS. Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis. Dig Dis Sci. 2012;57:813-819. [PMID: 22147252 DOI: 10.1007/s10620-011-1995-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
150 Jung IH, Yoon SM, Kwak J, Park JH, Song SY, Lee SW, Ahn SD, Choi EK, Kim JH. High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma. Oncotarget. 2017;8:15182-15192. [PMID: 28146433 DOI: 10.18632/oncotarget.14858] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
151 Yan B, Bai DS, Zhang C, Qian JJ, Jin SJ, Jiang GQ. Characteristics and risk differences of different tumor sizes on distant metastases of hepatocellular carcinoma: A retrospective cohort study in the SEER database. Int J Surg 2020;80:94-100. [PMID: 32619622 DOI: 10.1016/j.ijsu.2020.06.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
152 Ma ZJ, Wang Y, Li HF, Liu MH, Bi FR, Ma L, Ma H, Yan HL. LncZEB1-AS1 regulates hepatocellular carcinoma bone metastasis via regulation of the miR-302b-EGFR-PI3K-AKT axis. J Cancer 2020;11:5118-28. [PMID: 32742459 DOI: 10.7150/jca.45995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
153 Craig MJ, Loberg RD. CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases. Cancer Metastasis Rev 2006;25:611-9. [PMID: 17160712 DOI: 10.1007/s10555-006-9027-x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 117] [Article Influence: 8.1] [Reference Citation Analysis]
154 Tang A, Fowler KJ, Chernyak V, Chapman WC, Sirlin CB. LI-RADS and transplantation for hepatocellular carcinoma. Abdom Radiol 2018;43:193-202. [DOI: 10.1007/s00261-017-1210-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
155 Zhang S, Xu Y, Xie C, Ren L, Wu G, Yang M, Wu X, Tang M, Hu Y, Li Z, Yu R, Liao X, Mo S, Wu J, Li M, Song E, Qi Y, Song L, Li J. RNF219/α-Catenin/LGALS3 Axis Promotes Hepatocellular Carcinoma Bone Metastasis and Associated Skeletal Complications. Adv Sci (Weinh) 2021;8:2001961. [PMID: 33643786 DOI: 10.1002/advs.202001961] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
156 Salehi M, Yee T, Alatevi E, Thein Y. Clinically Silent Intracardiac Metastasis with Extremely Poor Prognosis in a Patient with Hepatocellular Carcinoma. Case Rep Gastroenterol 2017;11:416-21. [PMID: 28878615 DOI: 10.1159/000477379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
157 Chen C, Wu K, Lin W, Lan T, Wang S, Sun J, Weng P, Yen R, Yang R. High false negative rate of Tc-99m MDP whole-body bone scintigraphy in detecting skeletal metastases for patients with hepatoma. Journal of the Formosan Medical Association 2012;111:140-6. [DOI: 10.1016/j.jfma.2011.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
158 Shapey J, Li Y, Gonzales M, Drummond K. Brain metastases from hepatocellular carcinoma in two Caucasian Australian patients. J Clin Neurosci 2012;19:1442-5. [PMID: 22898198 DOI: 10.1016/j.jocn.2012.02.009] [Reference Citation Analysis]
159 Xu M, Doyle MM, Banan B, Vachharajani N, Wang X, Saad N, Fowler K, Brunt EM, Lin Y, Chapman WC. Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation. J Am Coll Surg. 2017;225:28-40. [PMID: 28400300 DOI: 10.1016/j.jamcollsurg.2017.03.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
160 Dai W, Wang F, He L, Lin C, Wu S, Chen P, Zhang Y, Shen M, Wu D, Wang C, Lu J, Zhou Y, Xu X, Xu L, Guo C. Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: Partial mediation by the transcription factor NFAT 1: GENISTEIN INHIBITS HEPATOCELLULAR CARCINOMA CELL MIGRATION. Mol Carcinog 2015;54:301-11. [DOI: 10.1002/mc.22100] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
161 Aino H, Sumie S, Niizeki T, Kuromatsu R, Tajiri N, Nakano M, Satani M, Okamura S, Shimose S, Miyahara K, Torimura T. The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis. Mol Clin Oncol 2016;5:83-8. [PMID: 27330772 DOI: 10.3892/mco.2016.879] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
162 Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Tajiri N, Satani M, Niizeki T, Aino H, Okamura S, Iwamoto H. Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study. Cancer Med. 2015;4:1836-1843. [PMID: 26471348 DOI: 10.1002/cam4.548] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
163 Zhou Y, Zhou X, Ma J, Zhang W, Yan Z, Luo J. Nomogram for Predicting the Prognosis of Patients with Hepatocellular Carcinoma Presenting with Pulmonary Metastasis. Cancer Manag Res 2021;13:2083-94. [PMID: 33688251 DOI: 10.2147/CMAR.S296020] [Reference Citation Analysis]
164 Arora S, Harmath C, Catania R, Mandler A, Fowler KJ, Borhani AA. Hepatocellular carcinoma: metastatic pathways and extra-hepatic findings. Abdom Radiol (NY) 2021;46:3698-707. [PMID: 34091729 DOI: 10.1007/s00261-021-03151-3] [Reference Citation Analysis]
165 Yoo D, Kim KM, Jin Y, Shim JH, Ko G, Yoon H, Sung K, Lee J, Kang Y, Lim Y, Lee HC, Chung Y, Lee YS, Suh DJ. Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: Does transarterial chemoembolization improve survival in these patients?: Efficacy of TACE in HCC with metastasis. Journal of Gastroenterology and Hepatology 2011;26:145-54. [DOI: 10.1111/j.1440-1746.2010.06341.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 6.6] [Reference Citation Analysis]
166 Kim JI, Song CH, Gong HS. FINGER SKIN METASTASIS FROM HEPATOCELLULAR CARCINOMA: A CASE REPORT. Hand Surg 2012;17:131-4. [DOI: 10.1142/s0218810412720148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
167 Seo HJ, Choi YJ, Kim HJ, Jeong YH, Cho A, Lee JH, Yun M, Choi HJ, Lee JD, Kang WJ. Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using (18)F-FDG PET/CT and (99m)Tc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation. Nucl Med Mol Imaging 2011;45:203-11. [PMID: 24900005 DOI: 10.1007/s13139-011-0099-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
168 Hayashi S, Tanaka H, Hoshi H. Palliative external-beam radiotherapy for bone metastases from hepatocellular carcinoma. World J Hepatol 2014; 6(12): 923-929 [PMID: 25544879 DOI: 10.4254/wjh.v6.i12.923] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
169 Wang S, Wang A, Lin J, Xie Y, Wu L, Huang H, Bian J, Yang X, Wan X, Zhao H, Huang J. Brain metastases from hepatocellular carcinoma: recent advances and future avenues. Oncotarget 2017;8:25814-29. [PMID: 28445959 DOI: 10.18632/oncotarget.15730] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
170 Xiang ZL, Zeng ZC, Tang ZY, Fan J, He J, Zeng HY, Zhu XD. Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma. Oncologist 2011;16:1028-39. [PMID: 21665914 DOI: 10.1634/theoncologist.2010-0358] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
171 Zachau L, Zeckey C, Schlue J, Sander J, Meyer-Heithuis C, Winkler M, Klempnauer J, Schrem H. Haematogenous abdominal wall metastasis of differentiated, alpha-fetoprotein-negative hepatocellular carcinoma after previous antiandrogen therapy within a site of lipoma manifestation since childhood. World J Surg Oncol 2012;10:98. [PMID: 22647077 DOI: 10.1186/1477-7819-10-98] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
172 Hiraki T, Gobara H, Mimura H, Yagi T, Sano Y, Tanaka N, Kanazawa S. Long-term Survival after Radiofrequency Ablation for Pulmonary Metastasis from Hepatocellular Carcinoma: Report of Two Cases. Journal of Vascular and Interventional Radiology 2009;20:1106-7. [DOI: 10.1016/j.jvir.2009.04.061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
173 陈珑, 候本新, 张相杰, 黄平. 70例海南三亚黎族原发性肝癌患者个体化治疗远期疗效及预后的相关因素. 世界华人消化杂志 2016; 24(20): 3188-3194 [DOI: 10.11569/wcjd.v24.i20.3188] [Reference Citation Analysis]
174 Abouzied MM, Alhinti N, AlMuhaideb A, Al Sugair AS, Al Qahtani M. Extrahepatic metastases from hepatocellular carcinoma: multimodality image evaluation. Nucl Med Commun 2021;42:583-91. [PMID: 33625188 DOI: 10.1097/MNM.0000000000001380] [Reference Citation Analysis]
175 Ochi H, Hirooka M, Hiraoka A, Koizumi Y, Abe M, Sogabe I, Ishimaru Y, Furuya K, Miyagawa M, Kawasaki H, Michitaka K, Takada Y, Mochizuki T, Hiasa Y. 18F-FDG-PET/CT predicts the distribution of microsatellite lesions in hepatocellular carcinoma. Mol Clin Oncol. 2014;2:798-804. [PMID: 25054048 DOI: 10.3892/mco.2014.328] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
176 Terada T. Hepatocellular carcinoma metastatic to the gingiva as a first manifestation of hepatocellular carcinoma. J Maxillofac Oral Surg 2011;10:271-4. [PMID: 22942601 DOI: 10.1007/s12663-011-0187-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
177 Yuan BY, Hu Y, Zhang L, Chen YH, Dong YY, Zeng ZC. Radiotherapy for adrenal gland metastases from hepatocellular carcinoma. Clin Transl Oncol. 2017;19:1154-1160. [PMID: 28357632 DOI: 10.1007/s12094-017-1654-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
178 Roth CG, Mitchell DG. Hepatocellular carcinoma and other hepatic malignancies: MR imaging. Radiol Clin North Am. 2014;52:683-707. [PMID: 24889167 DOI: 10.1016/j.rcl.2014.02.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
179 Zhang L, Chen L, Wang J, Mu W, Zhou D, Huang X, Shi Y. CT-guided radioactive 125I seed implantation treatment of multiple pulmonary metastases of hepatocellular carcinoma. Clinical Radiology 2014;69:624-9. [DOI: 10.1016/j.crad.2014.01.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
180 Hu C, Yang J, Huang Z, Liu C, Lin Y, Tong Y, Fan Z, Chen B, Wang C, Zhao CL. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma. BMC Cancer 2020;20:494. [PMID: 32487048 DOI: 10.1186/s12885-020-06995-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Chen YX, Zeng ZC, Fan J, Tang ZY, Zhou J, Zeng MS, Zhang JY, Sun J. Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases. Clin Transl Oncol. 2013;15:732-740. [PMID: 23381897 DOI: 10.1007/s12094-012-0997-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
182 Shinya S, Noritomi T, Yamauchi Y, Sasaki T, Hamada Y, Yamashita Y. Two rare metachronous metastases of hepatocellular carcinoma after liver transplantation. Int Surg 2013;98:432-6. [PMID: 24229037 DOI: 10.9738/INTSURG-D-13-00026.1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
183 Liu Y, Hao S, Ji N, Wang J, Zhang L. Combination of Anti-Programmed Death 1 Therapy and Apatinib for a Patient with Hepatocellular Carcinoma and Brain Metastasis: Case Report and Literature Review. World Neurosurg 2020;143:114-7. [PMID: 32534262 DOI: 10.1016/j.wneu.2020.06.015] [Reference Citation Analysis]
184 Kattepur AK, Patil DB, Krishnamoorthy N, Srinivas KG, Swamy S, Amarendra S, Gopinath KS. Isolated nasopharyngeal metastasis from hepatocellular carcinoma. Int J Surg Case Rep 2014;5:115-7. [PMID: 24509427 DOI: 10.1016/j.ijscr.2013.12.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
185 Hsieh MJ, Lu CH, Tsai NW, Lui CC, Chuang YC, Huang CR, Chen SF, Chang CC, Chang HW, Chang WN. Prediction, clinical characteristics and prognosis of intracerebral hemorrhage in hepatocellular carcinoma patients with intracerebral metastasis. J Clin Neurosci 2009;16:394-8. [PMID: 19147364 DOI: 10.1016/j.jocn.2008.05.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
186 Silvestre-Rodríguez J, Alonso-Gómez J, Sanchez-Lauro MDM, Cruz-Benavides F, Marchena-Gómez J. Post-traumatic rupture of a suprarenal metastasis of hepatocarcinoma. Cir Esp (Engl Ed) 2018;96:126-8. [PMID: 28662769 DOI: 10.1016/j.ciresp.2017.05.005] [Reference Citation Analysis]
187 Lee HJ, Kang HJ, Kim KM, Yu ES, Kim KH, Kim SM, Kim TW, Shim JH, Lim YS, Lee HC, Chung YH, Lee YS. Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:60-70. [PMID: 25834803 DOI: 10.3350/cmh.2015.21.1.60] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
188 Kamimura K. Identification of molecular transition of hepatocellular carcinoma: a novel method to predict the initiation of metastasis. Stem Cell Investig 2019;6:5. [PMID: 30976602 DOI: 10.21037/sci.2019.02.02] [Reference Citation Analysis]
189 Nakamura A, Esaki M, Nakagawa K, Asakura K, Kishi Y, Nara S, Shimada K, Watanabe SI. Three risk factors for pulmonary metastasectomy in patients with hepatocellular carcinoma. Gen Thorac Cardiovasc Surg 2019;67:782-7. [PMID: 30820914 DOI: 10.1007/s11748-019-01082-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
190 Zhang Y, Zhang H, Wu W, Zhang F, Liu S, Wang R, Sun Y, Tong T, Jing X. Folate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis models. Int J Nanomedicine 2014;9:2019-30. [PMID: 24790440 DOI: 10.2147/IJN.S57744] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
191 Lassandro G, Picchi SG, Bianco A, Di Costanzo G, Coppola A, Ierardi AM, Lassandro F. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study. Med Oncol. 2020;37:25. [PMID: 32166529 DOI: 10.1007/s12032-020-01352-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
192 Yang X, Xu H, Zuo B, Yang X, Bian J, Long J, Wang D, Zhang J, Ning C, Wang Y, Xun Z, Wang Y, Lu X, Mao Y, Sang X, Zhao H. Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy. Hepatobiliary Surg Nutr 2021;10:434-42. [PMID: 34430522 DOI: 10.21037/hbsn-21-188] [Reference Citation Analysis]
193 Magliocca KR, Kuklani R, Dooreck BS. Occult Hepatocellular Carcinoma Metastatic to the Mandible. Clinical Gastroenterology and Hepatology 2009;7:A22-A22.e1. [DOI: 10.1016/j.cgh.2008.08.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
194 Menis J, Fontanella C, Follador A, Fasola G, Aprile G. Brain metastases from gastrointestinal tumours: Tailoring the approach to maximize the outcome. Critical Reviews in Oncology/Hematology 2013;85:32-44. [DOI: 10.1016/j.critrevonc.2012.04.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
195 Tanaka K, Shimada H, Matsuo K, Takeda K, Nagano Y, Togo S. Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection. World J Surg. 2008;32:1738-1747. [PMID: 18463920 DOI: 10.1007/s00268-008-9613-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
196 Gong LI, Zhang WD, Mu XR, Han XJ, Yao LI, Zhu SJ, Zhang FQ, Li YH, Zhang W. Hepatocellular carcinoma metastasis to the gingival soft tissues: A case report and review of the literature. Oncol Lett 2015;10:1565-8. [PMID: 26622710 DOI: 10.3892/ol.2015.3422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
197 Jan YJ, Ko BS, Liu TA, Wu YM, Liang SM, Chen SC, Wang J, Liou JY. Expression of partitioning defective 3 (Par-3) for predicting extrahepatic metastasis and survival with hepatocellular carcinoma. Int J Mol Sci 2013;14:1684-97. [PMID: 23322019 DOI: 10.3390/ijms14011684] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
198 Yoon KT, Kim JK, Kim DY, Ahn SH, Lee JD, Yun M, Rha SY, Chon CY, Han KH. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Oncology. 2007;72 Suppl 1:104-110. [PMID: 18087190 DOI: 10.1159/000111715] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]
199 Katamura Y, Aikata H, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Ishikawa M, Hieda M, Kakizawa H, Chayama K. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases: Chemotherapy for hepatoma. Journal of Gastroenterology and Hepatology 2010;25:1117-22. [DOI: 10.1111/j.1440-1746.2009.06110.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
200 Kwon JB, Park K, Kim YD, Seo JH, Moon SW, Cho DG, Kim YW, Kim DG, Yoon SK, Lim HW. Clinical outcome after pulmonary metastasectomy from primary hepatocellular carcinoma: Analysis of prognostic factors. World J Gastroenterol 2008; 14(37): 5717-5722 [PMID: 18837090 DOI: 10.3748/wjg.14.5717] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
201 Yoo JJ, Lee JH, Lee SH, Lee M, Lee DH, Cho Y, Lee YB, Yu SJ, Kim HC, Kim YJ, Yoon JH, Kim CY, Lee HS. Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases. PLoS One. 2014;9:e113926. [PMID: 25427152 DOI: 10.1371/journal.pone.0113926] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
202 Hiraki T, Yamakado K, Ikeda O, Matsuoka T, Kaminou T, Yamagami T, Gobara H, Mimura H, Kawanaka K, Takeda K, Yamashita Y, Inoue Y, Ogawa T, Nishimura T, Kanazawa S. Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan. J Vasc Interv Radiol. 2011;22:741-748. [PMID: 21531575 DOI: 10.1016/j.jvir.2011.02.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
203 Kim SU, Kim DY, Park JY, Ahn SH, Nah HJ, Chon CY, Han K. Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors. J Cancer Res Clin Oncol 2008;134:1377-84. [DOI: 10.1007/s00432-008-0410-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
204 Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, Goto T, Omata M, Yoshida H, Koike K. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer. 2011;117:4475-4483. [PMID: 21437884 DOI: 10.1002/cncr.25960] [Cited by in Crossref: 228] [Cited by in F6Publishing: 209] [Article Influence: 22.8] [Reference Citation Analysis]
205 Fujihara H, Chikazu D, Saijo H, Suenaga H, Mori Y, Iino M, Hamada Y, Takato T. Metastasis of hepatocellular carcinoma into the mandible with radiographic findings mimicking a radicular cyst: a case report. J Endod 2010;36:1593-6. [PMID: 20728734 DOI: 10.1016/j.joen.2010.05.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
206 Guo X, Xu Y, Wang X, Lin F, Wu H, Duan J, Xiong Y, Han X, Baklaushev VP, Xiong S, Chekhonin VP, Peltzer K, Wang G, Zhang C. Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation. Med Sci Monit 2019;25:1105-12. [PMID: 30739123 DOI: 10.12659/MSM.913470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
207 Nakamura M, Nagano H, Wada H, Noda T, Ota H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M. A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha. J Gastroenterol 2006;41:1120-5. [PMID: 17160524 DOI: 10.1007/s00535-006-1907-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
208 Kuehl H, Stattaus J, Forsting M, Antoch G. Transhepatic CT-guided radiofrequency ablation of adrenal metastases from hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2008;31:1210-1214. [PMID: 18584241 DOI: 10.1007/s00270-008-9377-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
209 Ince V, Gundogan E, Tolan K, Kayaalp C, Yilmaz S. Resection of Adrenal Metastasis Invading Left Renal Vein Following Living Donor Liver Transplantation for Hepatocellular Carcinoma. J Gastrointest Cancer 2020;51:311-3. [PMID: 31098842 DOI: 10.1007/s12029-019-00252-7] [Reference Citation Analysis]
210 Cho Y, Lee DH, Lee YB, Lee M, Yoo JJ, Choi WM, Cho YY, Paeng JC, Kang KW, Chung JK, Yu SJ, Lee JH, Yoon JH, Lee HS, Kim YJ. Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma? PLoS One 2014;9:e105679. [PMID: 25153834 DOI: 10.1371/journal.pone.0105679] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
211 Xiang ZL, Zeng ZC, Fan J, Tang ZY, He J, Zeng HY, Chang JY. The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Mol Biol Rep 2012;39:2021-9. [PMID: 21647551 DOI: 10.1007/s11033-011-0949-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
212 Magaña M, Gomez LM. Skin metastasis from hepatocarcinoma. Am J Dermatopathol. 2009;31:502-505. [PMID: 19542932 DOI: 10.1097/DAD.0b013e31819d095e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
213 Xiang Z, Bai M, Li G, Zou B, Zhong Z, Gao F, Wu C, Huang M, Zhang F. Safety and efficacy of 125I brachytherapy for bilateral lung recurrences from hepatocellular carcinoma after resection or ablation. J Cancer Res Clin Oncol 2019;145:1907-16. [PMID: 31161374 DOI: 10.1007/s00432-019-02943-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
214 Vargas J, Gowans M, Vandergrift WA, Hope J, Giglio P. Metastatic hepatocellular carcinoma with associated spinal cord compression. Am J Med Sci. 2011;341:148-152. [PMID: 21107234 DOI: 10.1097/maj.0b013e3181f7a49a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
215 Chang CW, Wang TE, Chen LT, Chang WH, Leu YS, Fan YK, Chan YJ. Unusual presentation of metastatic hepatocellular carcinoma in the nasal septum: a case report and review of the literature. Med Oncol 2008;25:264-8. [PMID: 18040899 DOI: 10.1007/s12032-007-9028-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
216 Dantas E, Matos D, Coelho M, Sequeira C, Cardoso C, Oliveira AP. Hepatocellular Carcinoma with Atrial Extension: A Case Report. GE Port J Gastroenterol 2021;28:360-3. [PMID: 34604468 DOI: 10.1159/000511643] [Reference Citation Analysis]
217 Matoba M, Tsuchiya H, Kondo T, Ota K. Stereotactic body radiotherapy delivered with IMRT for oligometastatic regional lymph node metastases in hepatocellular carcinoma: a single-institutional study. J Radiat Res. 2020;61:776-783. [PMID: 32845298 DOI: 10.1093/jrr/rraa067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
218 Imai M, Ishikawa T, Okoshi M, Tomiyoshi K, Kojima Y, Horigome R, Nozawa Y, Sano T, Iwanaga A, Honma T, Nemoto T, Takeda K, Nishikura K, Ishihara N, Yoshida T. Hemorrhagic Gastric Metastasis from Hepatocellular Carcinoma Successfully Treated Using Coil Embolization of the Left Gastric Artery. Intern Med 2019;58:2179-83. [PMID: 30996163 DOI: 10.2169/internalmedicine.2172-18] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
219 Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S. Hepatitis B virus infection predicts extrahepatic metastasis after hepatic resection in patients with large hepatocellular carcinoma. Ann Surg Oncol. 2007;14:3181-3187. [PMID: 17846843 DOI: 10.1245/s10434-007-9570-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
220 Zhang JY, Xu D, Liu ZZ, Li Y, Wang LJ, Xing BC. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis. Chin Med J (Engl) 2017;130:470-6. [PMID: 28218222 DOI: 10.4103/0366-6999.199839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
221 Tameda M, Shiraki K, Takei Y. Isolated metastasis of hepatocellular carcinoma in the right ventricle. Clin Gastroenterol Hepatol 2014;12:A25-6. [PMID: 23958560 DOI: 10.1016/j.cgh.2013.08.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
222 Alhawassi S. Rare Case of Hepatocellular Carcinoma Invading the Right Atrium. Saudi J Med Med Sci 2017;5:189-91. [PMID: 30787785 DOI: 10.4103/1658-631X.204872] [Reference Citation Analysis]
223 Mizuguchi S, Nishiyama N, Izumi N, Tsukioka T, Komatsu H, Iwata T, Tanaka S, Takemura S, Kubo S. Clinical Significance of Multiple Pulmonary Metastasectomy for Hepatocellular Carcinoma. World J Surg. 2016;40:380-387. [PMID: 26306890 DOI: 10.1007/s00268-015-3213-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
224 Al-Sharydah AM, Al-Abdulwahhab AH, Alghnimi IA, El Shawarby MA, Katbi FA. Mastalgia as an atypical presentation of hepatocellular carcinoma: a case report. World J Surg Oncol 2017;15:58. [PMID: 28279206 DOI: 10.1186/s12957-017-1133-4] [Reference Citation Analysis]
225 Kawamura E, Shiomi S, Kotani K, Kawabe J, Hagihara A, Fujii H, Uchida-Kobayashi S, Iwai S, Morikawa H, Enomoto M, Murakami Y, Tamori A, Kawada N. Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma. J Gastroenterol Hepatol 2014;29:1722-7. [PMID: 24730671 DOI: 10.1111/jgh.12611] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
226 Li W, Zhang S. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells. Oncol Res 2017;25:285-93. [PMID: 27629543 DOI: 10.3727/096504016X14732523471442] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
227 Honda S, Saito Y, Sawada K, Hasebe T, Nakajima S, Okumura T. Repeated Perforation of the Gallbladder in a Patient with Hepatocellular Carcinoma Receiving Lenvatinib. Intern Med 2020;59:657-62. [PMID: 31735795 DOI: 10.2169/internalmedicine.3806-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
228 Tsuchiya A, Imai M, Kamimura H, Togashi T, Watanabe K, Seki KI, Ishikawa T, Ohta H, Yoshida T, Kamimura T. Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil. World J Gastroenterol 2009; 15(14): 1779-1781 [PMID: 19360925 DOI: 10.3748/wjg.15.1779] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
229 Santini D, Pantano F, Riccardi F, Di Costanzo GG, Addeo R, Guida FM, Ceruso MS, Barni S, Bertocchi P, Marinelli S, Marchetti P, Russo A, Scartozzi M, Faloppi L, Santoni M, Cascinu S, Maiello E, Silvestris F, Tucci M, Ibrahim T, Masi G, Gnoni A, Comandone A, Fazio N, Conti A, Imarisio I, Pisconti S, Giommoni E, Cinieri S, Catalano V, Palmieri VO, Infante G, Aieta M, Trogu A, Gadaleta CD, Brunetti AE, Lorusso V, Silvestris N. Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey. PLoS One 2014;9:e105268. [PMID: 25170882 DOI: 10.1371/journal.pone.0105268] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
230 Matsushima-Nishiwaki R, Yamada N, Fukuchi K, Kozawa O. Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2. PLoS One 2018;13:e0209050. [PMID: 30543684 DOI: 10.1371/journal.pone.0209050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
231 Zhang XP, Gao YZ, Jiang YB, Wang K, Chen ZH, Guo WX, Shi J, Zhang YJ, Chen MS, Lau WY, Cheng SQ. A serological scoring system to predict lymph node metastasis in patients with hepatocellular carcinoma. HPB (Oxford) 2019;21:335-44. [PMID: 30104175 DOI: 10.1016/j.hpb.2018.07.013] [Reference Citation Analysis]
232 Meng XC, Chen BH, Huang JJ, Huang WS, Cai MY, Zhou JW, Guo YJ, Zhu KS. Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib. World J Gastroenterol 2018; 24(4): 484-493 [PMID: 29398869 DOI: 10.3748/wjg.v24.i4.484] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
233 Nadkarni S, Patkar S, Acharya R, Shah A, Patel S, Parray A, Goel M. Hepatocellular carcinoma metastasis to the buccal mucosa masquerading as oral cavity malignancy: Case report of a rare entity. Ann Hepatobiliary Pancreat Surg 2020;24:68-71. [PMID: 32181432 DOI: 10.14701/ahbps.2020.24.1.68] [Reference Citation Analysis]
234 Anwar AM, Nosir YF, Chamsi-Pasha MA, Ajam A, Chamsi-Pasha H. Right atrial metastasis mimicking myxoma in advanced hepatocellular carcinoma. Echocardiography 2010;27:80-3. [PMID: 19765072 DOI: 10.1111/j.1540-8175.2009.00963.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
235 Yokoo T, Patel AD, Lev-Cohain N, Singal AG, Yopp AC, Pedrosa I. Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging. Cancer Manag Res 2017;9:503-11. [PMID: 29081671 DOI: 10.2147/CMAR.S147097] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
236 Kow AW, Kwon CH, Song S, Shin M, Kim JM, Joh JW. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution. Ann Surg Oncol. 2012;19:2246-2255. [PMID: 22402812 DOI: 10.1245/s10434-012-2260-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
237 Kitano K, Murayama T, Sakamoto M, Nagayama K, Ueno K, Murakawa T, Nakajima J. Outcome and survival analysis of pulmonary metastasectomy for hepatocellular carcinoma. European Journal of Cardio-Thoracic Surgery 2012;41:376-82. [DOI: 10.1016/j.ejcts.2011.05.052] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
238 Pesis M, Taicher S, Greenberg G, Hirshberg A. Metastasis to the jaws as a first manifestation of hepatocellular carcinoma: report of a case and analysis of 41 cases. J Craniomaxillofac Surg 2014;42:1997-2001. [PMID: 25441863 DOI: 10.1016/j.jcms.2014.09.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
239 Hsiao SY, Chen SF, Chang CC, Lin CH, Chang WN, Lu CH, Chuang YC, Tsai NW. Central nervous system involvement in hepatocellular carcinoma: clinical characteristics and comparison of intracranial and spinal metastatic groups. J Clin Neurosci 2011;18:364-8. [PMID: 21247770 DOI: 10.1016/j.jocn.2010.04.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
240 Helal Tel A, Radwan NA, Shaker M. Extrahepatic metastases as initial manifestations of hepatocellular carcinoma: an Egyptian experience. Diagn Pathol 2015;10:82. [PMID: 26122043 DOI: 10.1186/s13000-015-0313-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
241 Arizono S, Isoda H, Hatano E, Togashi K. Uptake of gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic acid in metastatic adrenal tumour from hepatocellular carcinoma. Br J Radiol 2011;84:e182-5. [PMID: 21849360 DOI: 10.1259/bjr/20594229] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
242 Goto M, Sakamoto K, Kawano S, Munakata S, Kawai M, Ishiyama S, Sugimoto K, Takahashi M, Kojima Y, Tomita N, Saeki H, Shiina S. A case of simultaneous abdominal wall metastasis of hepatocellular carcinoma with long-term relapse-free survival after laparoscopic resection. Int Cancer Conf J 2021;10:217-21. [PMID: 34221835 DOI: 10.1007/s13691-021-00484-0] [Reference Citation Analysis]
243 Shinmura K, Choi YH, Shimohira M, Baba Y, Ikeda S, Hayashi S, Shibamoto Y, Koriyama C, Yoshiura T. Comparison of conservative treatment versus transcatheter arterial embolisation for the treatment of spontaneously ruptured hepatocellular carcinoma. Pol J Radiol 2018;83:e311-8. [PMID: 30627252 DOI: 10.5114/pjr.2018.77024] [Reference Citation Analysis]
244 Kim S, Choi Y, Kwak DW, Lee HS, Hur WJ, Baek YH, Lee SW. Prognostic factors in hepatocellular carcinoma patients with bone metastases. Radiat Oncol J 2019;37:207-14. [PMID: 31591869 DOI: 10.3857/roj.2019.00136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
245 Rodríguez S, Balbinotto Neto G, Kiss G, Brandão A; Liver Transplantation Group. Cost-effectiveness of whole-body bone scans in the pre-liver transplant assessment of patients with hepatocellular carcinoma in Southern Brazil. Clin Transplant 2016;30:399-406. [PMID: 26783162 DOI: 10.1111/ctr.12699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
246 Invenizzi F, Iavarone M, Donato MF, Mazzucco A, Torre M, Conforti S, Rimessi A, Zavaglia C, Schiavon M, Comacchio G, Rea F, Boetto R, Cillo U, Dondossola D, De Carlis L, Lampertico P, Nosotti M, Mendogni P. Pulmonary Resection for Metastasis of Hepatocellular Carcinoma Recurring After Liver Transplant: An Italian Multicenter Experience. Front Oncol. 2020;10:381. [PMID: 32351877 DOI: 10.3389/fonc.2020.00381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
247 Lin C, Liang H, Lee H, Huang G, Yang P, Ho M, Lee P, Tsang Y, Chen D, Sheu J, Chen C. Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis. Journal of Gastroenterology and Hepatology 2009;24:815-20. [DOI: 10.1111/j.1440-1746.2009.05848.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
248 Kato R, Sakamoto A, Noguchi T, Matsuda S, Terajima H. Solitary Metastasis of Hepatocellular Carcinoma to the Rectus Abdominis 13 Years After the Initial Treatment. ACG Case Rep J 2021;8:e00607. [PMID: 34036115 DOI: 10.14309/crj.0000000000000607] [Reference Citation Analysis]
249 He J, Zeng ZC, Tang ZY, Fan J, Zhou J, Zeng MS, Wang JH, Sun J, Chen B, Yang P, Pan BS. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer. 2009;115:2710-2720. [PMID: 19382203 DOI: 10.1002/cncr.24300] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 6.9] [Reference Citation Analysis]
250 Ma J, Zhang L, Bian HR, Lu ZG, Zhu L, Yang P, Zeng ZC, Xiang ZL. A Noninvasive Prediction Nomogram for Lymph Node Metastasis of Hepatocellular Carcinoma Based on Serum Long Noncoding RNAs. Biomed Res Int 2019;2019:1710670. [PMID: 31355249 DOI: 10.1155/2019/1710670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
251 Woo HY, Rhee H, Yoo JE, Kim SH, Choi GH, Kim DY, Woo HG, Lee HS, Park YN. Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects. Liver Int 2021. [PMID: 34490997 DOI: 10.1111/liv.15051] [Reference Citation Analysis]
252 Jung J, Yoon SM, Park HC, Nam TK, Seong J, Chie EK, Kim TH, Kim MS, Kim CY, Jang HS, Kim JH. Radiotherapy for Adrenal Metastasis from Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 13-05). PLoS One. 2016;11:e0152642. [PMID: 27022932 DOI: 10.1371/journal.pone.0152642] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
253 Ma J, Zhang L, Yang P, Zeng ZC, Xiang ZL. Integrated analysis of long noncoding RNA expression profiles in lymph node metastasis of hepatocellular carcinoma. Gene. 2018;676:47-55. [PMID: 29981417 DOI: 10.1016/j.gene.2018.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
254 Molina Infante J, Pérez Gallardo B, Prieto Bermejo AB, Fernández Bermejo M, Robledo Andrés P. [Bone metastases in a cirrhotic patient with normal alpha-fetoprotein levels and imaging tests: detection of hepatocarcinoma 6 months later]. Gastroenterol Hepatol 2007;30:370-1. [PMID: 17662222 DOI: 10.1157/13107575] [Reference Citation Analysis]
255 Young C, Munk PL. Hepatocellular carcinoma presenting as musculoskeletal metastases: A report of two cases. European Journal of Radiology Extra 2007;62:25-9. [DOI: 10.1016/j.ejrex.2007.01.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
256 Jang JW, Kay CS, You CR, Kim CW, Bae SH, Choi JY, Yoon SK, Han CW, Jung HS, Choi IB. Simultaneous Multitarget Irradiation Using Helical Tomotherapy for Advanced Hepatocellular Carcinoma With Multiple Extrahepatic Metastases. International Journal of Radiation Oncology*Biology*Physics 2009;74:412-8. [DOI: 10.1016/j.ijrobp.2008.08.034] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
257 Kashima M, Yamakado K, Takaki H, Kaminou T, Tanigawa N, Nakatsuka A, Takeda K. Radiofrequency ablation for the treatment of bone metastases from hepatocellular carcinoma. AJR Am J Roentgenol. 2010;194:536-541. [PMID: 20093621 DOI: 10.2214/ajr.09.2975] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
258 Xiang ZL, Zeng ZC, Tang ZY, Fan J, Zhuang PY, Liang Y, Tan YS, He J. Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. BMC Cancer. 2009;9:176. [PMID: 19508713 DOI: 10.1186/1471-2407-9-176] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
259 Lee E, Kim TG, Park HC, Yu JI, Lim DH, Nam H, Lee H, Lee JH. Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma. Radiat Oncol J. 2015;33:217-225. [PMID: 26484305 DOI: 10.3857/roj.2015.33.3.217] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
260 Lu Y, Hu J, Lin X, Li X. Bone metastases from hepatocellular carcinoma: clinical features and prognostic factors. Hepatobiliary & Pancreatic Diseases International 2017;16:499-505. [DOI: 10.1016/s1499-3872(16)60173-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
261 Xia F, Wu L, Lau WY, Li G, Huan H, Qian C, Ma K, Bie P. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis. PLoS One. 2014;9:e95889. [PMID: 24760012 DOI: 10.1371/journal.pone.0095889] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
262 Jan YJ, Ko BS, Hsu C, Chang TC, Chen SC, Wang J, Liou JY. Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma. Hum Pathol 2009;40:1384-90. [PMID: 19454363 DOI: 10.1016/j.humpath.2009.03.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
263 Alterio RE, Ju MR, Wang SC, Mansour JC, Yopp A, Porembka MR. Socioeconomic and racial/ethnic disparities in receipt of palliative care among patients with metastatic hepatocellular carcinoma. J Surg Oncol 2021;124:1365-72. [PMID: 34505295 DOI: 10.1002/jso.26672] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
264 Inagaki Y, Shiraki K, Takei Y. Gastric metastasis of hepatocellular carcinoma presenting as hematemesis. Clin Gastroenterol Hepatol 2014;12:A16-7. [PMID: 23962547 DOI: 10.1016/j.cgh.2013.08.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
265 Lin G, Xiao H, Zeng Z, Xu Z, He J, Sun T, Liu J, Guo G, Ji W, Hu Y. Constraints for symptomatic radiation pneumonitis of helical tomotherapy hypofractionated simultaneous multitarget radiotherapy for pulmonary metastasis from hepatocellular carcinoma. Radiother Oncol. 2017;123:246-250. [PMID: 28314468 DOI: 10.1016/j.radonc.2017.02.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
266 Jung KS, Park KH, Chon YE, Lee SR, Park YN, Lee DY, Seong JS, Park JY. A case of isolated metastatic hepatocellular carcinoma arising from the pelvic bone. Korean J Hepatol 2012;18:89-93. [PMID: 22511908 DOI: 10.3350/kjhep.2012.18.1.89] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
267 Nguyen V, George J, van der Poorten D. A maxillary mass in a HBV-cirrhotic patient. Liver Int 2012;32:988. [PMID: 22380542 DOI: 10.1111/j.1478-3231.2012.02780.x] [Reference Citation Analysis]
268 Chen R, Cheng Q, Owusu-Ansah KG, Song G, Jiang D, Zhou L, Xu X, Wu J, Zheng S. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma. Int J Biol Sci 2020;16:495-503. [PMID: 32015685 DOI: 10.7150/ijbs.39582] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
269 Aino H, Sumie S, Niizeki T, Kuromatsu R, Tajiri N, Nakano M, Satani M, Yamada S, Okamura S, Shimose S. Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis. Mol Clin Oncol. 2014;2:393-398. [PMID: 24772306 DOI: 10.3892/mco.2014.259] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
270 Katamura Y, Aikata H, Kimura Y, Azakami T, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Chayama K. Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-α in a hemodialysis patient. Hepatology Research 2009;39:415-20. [DOI: 10.1111/j.1872-034x.2008.00448.x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
271 Yoon KT, Choi JW, Park JY, Ahn SH, Paik YH, Lee KS, Han KH, Chon CY, Kim DY. Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases. Korean J Hepatol 2008;14:360. [DOI: 10.3350/kjhep.2008.14.3.360] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
272 Su C, Jin C, Han J, Hu X, Shi D, Meng F. Ultrasonographic assessment of right heart intracardiac mass in patients with hepatitis B virus infection. Eur J Gastroenterol Hepatol 2020;32:838-43. [PMID: 31725029 DOI: 10.1097/MEG.0000000000001589] [Reference Citation Analysis]
273 Kirstein MM, Voigtländer T, Schweitzer N, Hinrichs JB, Marquardt J, Wörns MA, Kloeckner R, Fründt TW, Ittrich H, Wacker F, Rodt T, Manns MP, Wege H, Weinmann A, Vogel A. Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease. United European Gastroenterol J 2018;6:238-46. [PMID: 29511553 DOI: 10.1177/2050640617716597] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
274 Souza e Silva IS, Gonzáles AM, Linhares MM, Salzedas Neto A, Szejnfeld D, D'Ippolito G, Lopes Filho Gde J, Lanzoni VP, Matos CA. Long-term follow-up after resection of thyroid metastases from hepatocellular carcinoma in noncirrhotic liver. Arq Bras Endocrinol Metabol 2013;57:327-31. [PMID: 23828439 DOI: 10.1590/s0004-27302013000400009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
275 Feng J, He Y, Wan J, Chen Z. Pulmonary metastases in newly diagnosed hepatocellular carcinoma: a population-based retrospective study. HPB (Oxford) 2020;22:1295-304. [PMID: 31892468 DOI: 10.1016/j.hpb.2019.12.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Kawaoka T, Aikata H, Kan H, Fujino H, Fukuhara T, Kobayashi T, Naeshiro N, Miyaki D, Hiramatsu A, Imamura M, Kawakami Y, Hyogo H, Chayama K. Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib: Sorafenib for HCC with extrahepatic metastasis. Hepatol Res 2014;44:1320-8. [DOI: 10.1111/hepr.12307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
277 Lin YS, Jung SM, Tsai FC, Yeh CN, Shiu TF, Wu HH, Lin PJ, Chu PH. Hepatoma with cardiac metastasis: An advanced cancer requiring advanced treatment. World J Gastroenterol 2007; 13(25): 3513-3516 [PMID: 17659700 DOI: 10.3748/wjg.v13.i25.3513] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
278 Arora A, Rajesh S, Bansal K, Sureka B, Patidar Y, Thapar S, Mukund A. Cirrhosis-related musculoskeletal disease: radiological review. Br J Radiol 2016;89:20150450. [PMID: 27356209 DOI: 10.1259/bjr.20150450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
279 Nam HC, Sung PS, Song DS, Kwon JH, Nam SW, Yoon DJ, Jang JW, Choi JY, Yoon SK, Moon SW, Jang HS, Park JS, Jeun SS, Hong YK, Bae SH. Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma. Int J Clin Oncol. 2019;24:666-676. [PMID: 30788672 DOI: 10.1007/s10147-019-01407-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
280 Zhang L, Niu H, Ma J, Yuan BY, Chen YH, Zhuang Y, Chen GW, Zeng ZC, Xiang ZL. The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma. Mol Cancer 2019;18:120. [PMID: 31349837 DOI: 10.1186/s12943-019-1044-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
281 Chen QF, Huang T, Shen L, Li W. Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study. PLoS One 2019;14:e0209293. [PMID: 30601858 DOI: 10.1371/journal.pone.0209293] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
282 Kishi Y, Hasegawa K, Sugawara Y, Kokudo N. Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol. 2011;2011:728103. [PMID: 21994868 DOI: 10.4061/2011/728103] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
283 Herath HM, Kulatunga A. Large hepatocellular carcinoma in a non-cirrhotic liver with peritoneal and omental metastasis in a healthy man: a case report. J Med Case Rep 2017;11:34. [PMID: 28173830 DOI: 10.1186/s13256-017-1203-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
284 Gong L, Zheng M, Li Y, Zhang W, Bu W, Shi L, Yan H. Seminal vesicle metastasis after partial hepatectomy for hepatocellular carcinoma. BMC Cancer. 2011;11:111. [PMID: 21443783 DOI: 10.1186/1471-2407-11-111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
285 Wong TCL, To KF, Hou SSM, Yip SKH, Ng CF. Late retroperitoneal recurrence of hepatocellular carcinoma 12 years after initial diagnosis. World J Gastroenterol 2010; 16(17): 2187-2189 [PMID: 20440862 DOI: 10.3748/wjg.v16.i17.2187] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
286 Jeong GH, Ye BD, Myung SJ. [Multiple colonic metastases from hepatocellular carcinoma]. Korean J Gastroenterol 2011;58:288-92. [PMID: 22113048 DOI: 10.4166/kjg.2011.58.5.288] [Reference Citation Analysis]
287 Wakasugi M, Ueshima S, Akamatsu H, Tori M, Oshita M, Tsujimoto M, Nishida T. Gallbladder metastasis from hepatocellular carcinoma: Report of a case and review of literature. Int J Surg Case Rep 2012;3:455-9. [PMID: 22743008 DOI: 10.1016/j.ijscr.2012.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]